Independent Age: 72 Director since: 2020 Board Committees Science Other Public Company Board Service: None CAREER HIGHLIGHTS Sonoma Biotherapeutics, Inc. , a clinical-stage biotechnology company developing engineered regulatory T cell therapies to treat serious autoimmune and inflammatory diseases President and Chief Executive Officer (2019-2025) University of California San Francisco Diabetes Center A.W. and Mary Margaret Clausen Distinguished Professor Emeritus in the Diabetes Center at University of California San Francisco, where he has been a member of the faculty and served in various other roles since 2020, including the Director of the Diabetes Center from 2000 to 2019 Parker Institute for Cancer Immunotherapy President and Chief Executive Officer (2015-2019) OTHER PROFESSIONAL HIGHLIGHTS AND ITEMS OF NOTE Managing Director at Vie Ventures, a life sciences venture capital firm focused on autoimmune and immune-mediated diseases (since 2026) Published more than 500 papers focused on T-cell activation and immune tolerance in autoimmunity, organ transplantation and cancer; his research has led to the development of multiple immunotherapies, including the first medicine approved by the FDA to delay/prevent autoimmune Type 1 diabetes and the first FDA-approved checkpoint inhibitor for the treatment of metastatic melanoma and other cancers Founding director of the Immune Tolerance Network, the largest National Institutes of Health-funded multicenter clinical immunology research program Member of the Blue Ribbon Panel, appointed by then Vice President Joe Biden, as a member of the National Cancer Moonshot Task Force Member of the National Academy of Sciences, National Academy of Medicine and American Academy of Arts and Sciences Recipient of a prestigious Guggenheim Fellowship Former Ludwig Professor and Director of the Ben May Institute at the University of Chicago Former director of Provention Bio, Inc. (2013-2022) RELEVANT SKILLS AND EXPERIENCE Internationally-recognized leader in the field of immunotherapy and related fields , with a distinguished scientific and academic career spanning four decades Strong leadership experience in the healthcare industry